146 related articles for article (PubMed ID: 31851922)
1. Topologically Associated Domains Delineate Susceptibility to Somatic Hypermutation.
Senigl F; Maman Y; Dinesh RK; Alinikula J; Seth RB; Pecnova L; Omer AD; Rao SSP; Weisz D; Buerstedde JM; Aiden EL; Casellas R; Hejnar J; Schatz DG
Cell Rep; 2019 Dec; 29(12):3902-3915.e8. PubMed ID: 31851922
[TBL] [Abstract][Full Text] [Related]
2. Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.
Komori A; Xu Z; Wu X; Zan H; Casali P
Mol Immunol; 2006 Apr; 43(11):1817-26. PubMed ID: 16412510
[TBL] [Abstract][Full Text] [Related]
3. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences.
Yang SY; Fugmann SD; Schatz DG
J Exp Med; 2006 Dec; 203(13):2919-28. PubMed ID: 17178919
[TBL] [Abstract][Full Text] [Related]
4. Identification of core DNA elements that target somatic hypermutation.
Kohler KM; McDonald JJ; Duke JL; Arakawa H; Tan S; Kleinstein SH; Buerstedde JM; Schatz DG
J Immunol; 2012 Dec; 189(11):5314-26. PubMed ID: 23087403
[TBL] [Abstract][Full Text] [Related]
5. Ig Enhancers Increase RNA Polymerase II Stalling at Somatic Hypermutation Target Sequences.
Tarsalainen A; Maman Y; Meng FL; Kyläniemi MK; Soikkeli A; Budzyńska P; McDonald JJ; Šenigl F; Alt FW; Schatz DG; Alinikula J
J Immunol; 2022 Jan; 208(1):143-154. PubMed ID: 34862258
[TBL] [Abstract][Full Text] [Related]
6. Targeting of somatic hypermutation.
Odegard VH; Schatz DG
Nat Rev Immunol; 2006 Aug; 6(8):573-83. PubMed ID: 16868548
[TBL] [Abstract][Full Text] [Related]
7. A critical context-dependent role for E boxes in the targeting of somatic hypermutation.
McDonald JJ; Alinikula J; Buerstedde JM; Schatz DG
J Immunol; 2013 Aug; 191(4):1556-66. PubMed ID: 23836058
[TBL] [Abstract][Full Text] [Related]
8. Attracting AID to targets of somatic hypermutation.
Tanaka A; Shen HM; Ratnam S; Kodgire P; Storb U
J Exp Med; 2010 Feb; 207(2):405-15. PubMed ID: 20100870
[TBL] [Abstract][Full Text] [Related]
9. Episomal vectors to monitor and induce somatic hypermutation in human Burkitt-Lymphoma cell lines.
Rückerl F; Busse B; Bachl J
Mol Immunol; 2006 Apr; 43(10):1645-52. PubMed ID: 16310251
[TBL] [Abstract][Full Text] [Related]
10. Targeting of somatic hypermutation by immunoglobulin enhancer and enhancer-like sequences.
Buerstedde JM; Alinikula J; Arakawa H; McDonald JJ; Schatz DG
PLoS Biol; 2014 Apr; 12(4):e1001831. PubMed ID: 24691034
[TBL] [Abstract][Full Text] [Related]
11. Splicing regulator SRSF1-3 that controls somatic hypermutation of IgV genes interacts with topoisomerase 1 and AID.
Kumar Singh A; Tamrakar A; Jaiswal A; Kanayama N; Agarwal A; Tripathi P; Kodgire P
Mol Immunol; 2019 Dec; 116():63-72. PubMed ID: 31622795
[TBL] [Abstract][Full Text] [Related]
12. Mutating for Good: DNA Damage Responses During Somatic Hypermutation.
Pilzecker B; Jacobs H
Front Immunol; 2019; 10():438. PubMed ID: 30915081
[TBL] [Abstract][Full Text] [Related]
13. Complex regulation of somatic hypermutation by cis-acting sequences in the endogenous IgH gene in hybridoma cells.
Ronai D; Iglesias-Ussel MD; Fan M; Shulman MJ; Scharff MD
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11829-34. PubMed ID: 16087866
[TBL] [Abstract][Full Text] [Related]
14. AID preferentially targets the top strand in nucleosome sequences.
Singh AK; Jaiswal A; Kodgire P
Mol Immunol; 2019 Aug; 112():198-205. PubMed ID: 31176199
[TBL] [Abstract][Full Text] [Related]
15. Interpretable deep learning reveals the role of an E-box motif in suppressing somatic hypermutation of AGCT motifs within human immunoglobulin variable regions.
Tambe A; MacCarthy T; Pavri R
Front Immunol; 2024; 15():1407470. PubMed ID: 38863710
[TBL] [Abstract][Full Text] [Related]
16. Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation.
Scherer F; Navarrete MA; Bertinetti-Lapatki C; Boehm J; Schmitt-Graeff A; Veelken H
Leuk Lymphoma; 2016; 57(1):151-60. PubMed ID: 25860234
[TBL] [Abstract][Full Text] [Related]
17. The Chromatin Reader ZMYND8 Regulates Igh Enhancers to Promote Immunoglobulin Class Switch Recombination.
Delgado-Benito V; Rosen DB; Wang Q; Gazumyan A; Pai JA; Oliveira TY; Sundaravinayagam D; Zhang W; Andreani M; Keller L; Kieffer-Kwon KR; Pękowska A; Jung S; Driesner M; Subbotin RI; Casellas R; Chait BT; Nussenzweig MC; Di Virgilio M
Mol Cell; 2018 Nov; 72(4):636-649.e8. PubMed ID: 30293785
[TBL] [Abstract][Full Text] [Related]
18. Transcription factor binding at Ig enhancers is linked to somatic hypermutation targeting.
Dinesh RK; Barnhill B; Ilanges A; Wu L; Michelson DA; Senigl F; Alinikula J; Shabanowitz J; Hunt DF; Schatz DG
Eur J Immunol; 2020 Mar; 50(3):380-395. PubMed ID: 31821534
[TBL] [Abstract][Full Text] [Related]
19. Target DNA sequence directly regulates the frequency of activation-induced deaminase-dependent mutations.
Chen Z; Viboolsittiseri SS; O'Connor BP; Wang JH
J Immunol; 2012 Oct; 189(8):3970-82. PubMed ID: 22962683
[TBL] [Abstract][Full Text] [Related]
20. Changes in RNA polymerase II progression influence somatic hypermutation of Ig-related genes by AID.
Kodgire P; Mukkawar P; Ratnam S; Martin TE; Storb U
J Exp Med; 2013 Jul; 210(7):1481-92. PubMed ID: 23752228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
